<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "aliskiren tab">
<dose><value>150</value>
<value>300</value>
</dose>
<route><value>PO</value>
</route>
<strength><value>150 mg</value>
</strength>
<frequency><value>DAILY</value>
</frequency>
<instruction></instruction>
<volume></volume>
<units><value>mg</value>
</units>
<Population></Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Aliskiren or Aliskiren-containing fixed combination products contraindicated in diabetic patients receiving an ACE inhibitor or Angiotensin receptor blocker product: increased incidence of non-fatal strokes, renal complications, hyperkalemia and hypotension; ALTITUDE study. Health Canada Advisory, 2012Jan18.</value>
</AdditionalNotes>
<BackgroundInformation></BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Non-Formulary.</value>
</AHSFormularyStatus>
<AHFSName><value>Renin-Angiotensin-Aldosterone System Inhibitors, Renin Inhibitors</value>
</AHFSName>
<HighAlert></HighAlert>
</drug>